FR2336944B1 - - Google Patents

Info

Publication number
FR2336944B1
FR2336944B1 FR7639469A FR7639469A FR2336944B1 FR 2336944 B1 FR2336944 B1 FR 2336944B1 FR 7639469 A FR7639469 A FR 7639469A FR 7639469 A FR7639469 A FR 7639469A FR 2336944 B1 FR2336944 B1 FR 2336944B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7639469A
Other languages
French (fr)
Other versions
FR2336944A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline RIT
Original Assignee
SmithKline RIT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline RIT filed Critical SmithKline RIT
Publication of FR2336944A1 publication Critical patent/FR2336944A1/fr
Application granted granted Critical
Publication of FR2336944B1 publication Critical patent/FR2336944B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/821—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR7639469A 1975-12-29 1976-12-29 Vaccins vivants contre la varicelle et le zona Granted FR2336944A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/644,787 US4008317A (en) 1975-12-29 1975-12-29 Varicella-zoster virus vaccine and preparation thereof

Publications (2)

Publication Number Publication Date
FR2336944A1 FR2336944A1 (fr) 1977-07-29
FR2336944B1 true FR2336944B1 (OSRAM) 1980-07-18

Family

ID=24586321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7639469A Granted FR2336944A1 (fr) 1975-12-29 1976-12-29 Vaccins vivants contre la varicelle et le zona

Country Status (6)

Country Link
US (1) US4008317A (OSRAM)
JP (1) JPS5282721A (OSRAM)
BE (1) BE849897A (OSRAM)
DE (1) DE2655691C2 (OSRAM)
FR (1) FR2336944A1 (OSRAM)
GB (1) GB1565830A (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043847A4 (en) * 1980-01-25 1982-07-06 Wistar Inst HIGHLY ATTENUED CHICKENPOX VIRUS VACCINE AND PRODUCTION THEREOF.
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
US4714678A (en) * 1982-10-13 1987-12-22 Smithkline-Rit Temperature sensitive strain of bovine viral diarrhoea virus
IT1213254B (it) * 1984-12-06 1989-12-14 Boehringer Biochemia Srl Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione.
ES2150906T3 (es) 1990-10-04 2000-12-16 Res Corp Technologies Inc Antigeno del virus varicella-zoster.
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
JP4562812B2 (ja) * 1992-07-17 2010-10-13 メルク・シャープ・エンド・ドーム・コーポレイション 帯状疱疹の予防または水痘関連ヘルペス後神経痛の緩和方法
US5879675A (en) * 1994-03-15 1999-03-09 Medical College Of Pennsylvania And Hahnemann University Compositions and methods for vaccines comprising α-galactosyl epitopes
US7666082B2 (en) * 2004-05-07 2010-02-23 Gamelogic Inc. Method and apparatus for conducting a game of chance
US10350289B2 (en) 2013-09-05 2019-07-16 Merck Sharp & Dohme Corp. Methods of immunization with varicella zoster virus antigen

Also Published As

Publication number Publication date
US4008317A (en) 1977-02-15
JPS5282721A (en) 1977-07-11
GB1565830A (en) 1980-04-23
FR2336944A1 (fr) 1977-07-29
BE849897A (fr) 1977-06-28
DE2655691C2 (de) 1985-08-14
JPS624370B2 (OSRAM) 1987-01-30
DE2655691A1 (de) 1977-07-14

Similar Documents

Publication Publication Date Title
FI762222A7 (OSRAM)
FR2336944B1 (OSRAM)
FI750640A7 (OSRAM)
FR2319083B1 (OSRAM)
JPS535052B2 (OSRAM)
JPS51141097U (OSRAM)
FR2332041B3 (OSRAM)
JPS51106028U (OSRAM)
JPS51110271U (OSRAM)
JPS51120332U (OSRAM)
JPS5269084U (OSRAM)
JPS5184187A (OSRAM)
JPS5231826U (OSRAM)
JPS525530U (OSRAM)
CH591151A5 (OSRAM)
CH592940A5 (OSRAM)
CH590430A5 (OSRAM)
CH589550A5 (OSRAM)
CH588917A5 (OSRAM)
CH588086A5 (OSRAM)
CH586152A5 (OSRAM)
CH598344A5 (OSRAM)
CH606761A5 (OSRAM)
CH584375A5 (OSRAM)
CH599666A5 (OSRAM)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse